Vincentius Liong on Nanorobot Swarms vs Blood Clots
Vincentius Liong/Leong, Business Advisor at VL Business Consulting Services, shared on LinkedIn:
”China designs nanorobot swarms that clear blood clots within minutes
Chinese scientists have created microscopic nanorobot swarms capable of dissolving dangerous blood clots inside veins within minutes.
Built from magnetic nanoparticles coated with enzymes, these tiny machines are guided by external magnetic fields to travel directly to blocked arteries. Once there, they spin and release clot-dissolving chemicals, restoring blood flow almost instantly.
The nanorobots are smaller than red blood cells and are injected into the bloodstream in a liquid solution. Doctors use MRI-like magnetic systems to steer the swarm toward the affected area. Once positioned, the swarm begins rotating, physically breaking down the clot while simultaneously releasing plasmin, a natural enzyme that dissolves fibrin — the protein mesh holding clots together.
Animal trials showed stunning results. Rabbits with blocked arteries regained full blood flow within 15 minutes, compared to hours or days for conventional drug treatments. Unlike clot-busting drugs, which spread throughout the body and can cause dangerous bleeding, the nanorobots deliver treatment only at the blockage site, reducing side effects.
One of the greatest advantages is precision. With real-time imaging, doctors can see exactly where the swarm moves, ensuring complete removal of blockages. This is especially critical in stroke patients, where every minute of delayed treatment can mean irreversible brain damage.
If human trials succeed, this could replace invasive surgeries and risky drug regimens. Millions who suffer from strokes, heart attacks, or deep vein thrombosis could benefit from a safer, faster therapy. Hospitals might one day keep nanorobot kits ready for emergencies, injecting life-saving swarms within seconds.
China’s innovation represents the merging of robotics, nanotechnology, and medicine — a future where tiny machines patrol our bloodstream to keep us alive.
Peer-Reviewed Scientific Publications:
tPA-anchored nanorobots for in vivo arterial recanalization at submillimeter-scale segments
Rapid Blood Clot Removal via Remote Delamination and Magnetization of Clot Debris
Untethered miniature robots for minimally invasive thrombus treatment: From bench to clinical trials
Application of nanotechnology and micro/nanorobots in thrombotic diseases
Nano-robotic based Thrombolysis: Dissolving Blood Clots using Nanobots
Advances of medical nanorobots for future cancer treatments
Tracking and navigation of a microswarm under laser speckle contrast imaging for targeted delivery
Magnetic Nanoparticles Mediated Thrombolysis–A Review
Credits CTTO”
Stay updated on all the innovations in the field of thrombosis with Hemostasis Today.
-
Sep 9, 2025, 23:00Blood Podcast Alert: LSD1 Inhibitors in SCD, Ruxolitinib+Dex in HLH, Low VWF Insights
-
Sep 9, 2025, 15:47AFib: A Hidden Stroke Risk
-
Sep 9, 2025, 07:56Mortality Risk in Thrombotic Thrombocytopenic Purpura․ Insights from Laboratory Biomarkers
-
Sep 9, 2025, 06:21Vincentius Liong on Nanorobot Swarms vs Blood Clots
-
Sep 9, 2025, 05:53Noel Hiney Highlights the Value of Blood Donation and Community Support
-
Sep 10, 2025, 08:20Flora Peyvandi on Caplacizumab: Which VWF Assays Truly Measure Treatment Effectiveness?
-
Sep 10, 2025, 03:36International Journal of Stroke: Rising Incidence of Stroke in Young Adults
-
Sep 9, 2025, 19:11John Fanikos Shares Greg Piazza's Presentation On The Results of The HI-Pro Trial
-
Sep 9, 2025, 08:15Taha Ahmed Highlights Rare Case: LV Fibroelastoma Mimicking Thrombus Leading to Takotsubo
-
Sep 9, 2025, 08:14JAMA Neurology: MRI Aneurysm Wall Enhancement Predicts Risk of Intracranial Aneurysm Growth or Rupture
-
Sep 9, 2025, 20:15Linking a Single Dominant Antibody to HIT: A Novel Study Led by Ishac Nazy, Donald Arnold, and John G. Kelton
-
Sep 8, 2025, 14:24Von Willebrand Factor as a Therapeutic Target․ From Development to Clinical Application
-
Sep 8, 2025, 02:35Reza Shojaei on the Real Worth of Hemoglobin Oxygen Carriers – HBOCs
-
Sep 7, 2025, 14:16Mary Kiige: Biological Hemoglobin Oxygen Carrier as a Lifesaving Oxygen Bridge
-
Sep 7, 2025, 14:13Breakthrough in Blood: Cécile Denis and INSERM Team Develop Nanobody Therapy for Type 1 VWD
-
Sep 9, 2025, 10:34James Douketis Receives the 2025 Distinguished Service Award in General Internal Medicine!
-
Sep 9, 2025, 08:07Hemophilia Federation of America Launches ‘Blood Brothers’ Podcast for Men With Bleeding Disorders
-
Sep 9, 2025, 04:57World Thrombosis Day 2025: Louise Bannon Invites Donations and Partnerships
-
Sep 8, 2025, 15:10Michael Makris on WHO’s Essential Medicines List Update: A Win for the Global Haemophilia Community
-
Sep 8, 2025, 14:26European Haemophilia Consortium Marks World PT Day: Physiotherapy Empowers People with Bleeding Disorders